Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Inari Medical’s product portfolio includes medical devices that treat pulmonary embolism, deep vein thrombosis, in-stent thrombosis and arteriovenous fistula. Stryker said the products are “hi ...

Oppenheimer initiated coverage of Inari Medical (NARI ... thrombectomy for the treatment of deep vein thrombosis and pulmonary embolism, notes the analyst, who says “competition is tough ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States. Read More on NARI: Inari Medical NewsMORE Related ...

Medical device maker Stryker said ... vascular diseases such as deep vein thrombosis and pulmonary embolism. “The acquisition of Inari expands Stryker's portfolio to provide life-saving ...

Analysts' ratings for Inari Medical NARI over the last quarter ... The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis ...

The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States. Read More on NARI: Inari Medical NewsMORE Related ...

NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical ... clot conditions including pulmonary embolism, deep vein thrombosis ...

Inari Medical, Inc. NARI shares rallied ... such as deep vein thrombosis and pulmonary embolism. This company is expected to post quarterly loss of $0.04 per share in its upcoming report, which ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s ... vascular conditions such as pulmonary embolism and deep vein thrombosis.